Skip to content

Nasdaq · CIK 0001658678

BSEM BioStem Technologies, Inc.

Insider trading from SEC Form 4. Last filing 3 d ago.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
6
with a Form 4 at this company

Signals

Open-market buys and sells at BioStem Technologies, Inc., scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Transactions

The last 20 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 7, 2026Vurst Andrew Smith-Van
Chief Operating Officer
MOption exercise
Common Stock
+250,000$2.00$500k1,789,8093 d ago
Oct 7, 2026Jason Matuszewski
Chief Executive Officer
MOption exercise
Common Stock
+250,000$2.00$500k1,553,5513 d ago
Oct 7, 2026Jason Matuszewski
Chief Executive Officer
MOption exercise
Options (Right to Buy)derivative
-250,000$0.00$02,000,0003 d ago
Oct 7, 2026Vurst Andrew Smith-Van
Chief Operating Officer
MOption exercise
Options (Right to Buy)derivative
-250,000$0.00$02,000,0003 d ago
Sep 15, 2026Kenneth Howard Warrington Jr
director
MOption exercise
Common Stock
+1,694$0.00$033,92825 d ago
Sep 15, 2026Jason Matuszewski
Chief Executive Officer
MOption exercise
Common Stock
+8,469$0.00$01,286,90225 d ago
Sep 15, 2026Brandon Poe
Chief Financial Officer
MOption exercise
Common Stock
+1,694$0.00$058,06225 d ago
Sep 15, 2026Vurst Andrew Smith-Van
Chief Operating Officer
MOption exercise
Common Stock
+7,622$0.00$01,530,23525 d ago
Sep 15, 2026Michael A Fortunato
Chief Accounting Officer
MOption exercise
Common Stock
+4,234$0.00$068,66425 d ago
Sep 17, 2026Jason Matuszewski
Chief Executive Officer
MOption exercise
Common Stock
+16,650$0.00$01,303,55225 d ago
Sep 17, 2026Vurst Andrew Smith-Van
Chief Operating Officer
MOption exercise
Common Stock
+9,574$0.00$01,539,80925 d ago
Sep 15, 2026Kenneth Howard Warrington Jr
director
MOption exercise
Restricted Stock Unitsderivative
-1,694$0.00$06,77325 d ago
Sep 15, 2026Brandon Poe
Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
-1,694$0.00$06,77525 d ago
Sep 15, 2026Michael A Fortunato
Chief Accounting Officer
MOption exercise
Restricted Stock Unitsderivative
-4,234$0.00$016,94125 d ago
Sep 15, 2026Vurst Andrew Smith-Van
Chief Operating Officer
MOption exercise
Restricted Stock Unitsderivative
-7,622$0.00$030,48725 d ago
Sep 15, 2026Jason Matuszewski
Chief Executive Officer
MOption exercise
Restricted Stock Unitsderivative
-8,469$0.00$033,87425 d ago
Sep 17, 2026Jason Matuszewski
Chief Executive Officer
MOption exercise
Restricted Stock Unitsderivative
-16,650$0.00$099,90025 d ago
Sep 17, 2026Vurst Andrew Smith-Van
Chief Operating Officer
MOption exercise
Restricted Stock Unitsderivative
-9,574$0.00$057,44225 d ago
Sep 9, 2026Barry Hassett
Chief Commercial Officer
MOption exercise
Common Stock
+500$0.00$05,00331 d ago
Sep 9, 2026Barry Hassett
Chief Commercial Officer
MOption exercise
Restricted Stock Unitsderivative
-500$0.00$04,49731 d ago

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

BSEM insider trading: BioStem Technologies, Inc. | InsiderTell